Research Library

The top resource for free research, white papers, reports, case studies, magazines, and eBooks.

Share Your Content with Us
on TradePub.com for readers like you. LEARN MORE
Personalized Therapy Selection: Investigation of Multiple Immune-Checkpoints
Request Your Free White Paper Now:

"Personalized Therapy Selection: Investigation of Multiple Immune-Checkpoints"

PD1 blockade through monoclonal antibody-based therapy has revolutionized the immunotherapeutic approach against solid tumors. However, only a small number of patients benefit from this treatment due to the lack of accurate methodology such as immunohistochemistry to guide patients that could respond to this immune checkpoint inhibitor therapy.

Understanding the tumor microenvironment complexity with a single biomarker is not accurate enough to predict the interaction of the drug in its site of action.

This white paper from Pyxant Labs presents a strategy in which the tumor microenvironment is deeply investigated to guide the patient efficiently toward single immune therapy or combination therapies, highlighting the relevance of simultaneously investigating multiple biomarkers to obtain an accurate picture of the immune contexture.


Offered Free by: Pyxant Labs Inc.
See All Resources from: Pyxant Labs Inc.

Recommended for Professionals Like You:

Thank you

This download should complete shortly. If the resource doesn't automatically download, please, click here.

Thank you

This download should complete shortly. If the resource doesn't automatically download, please, click here.

Thank you

This download should complete shortly. If the resource doesn't automatically download, please, click here.

Thank you

This download should complete shortly. If the resource doesn't automatically download, please, click here.